Clinical Trial Update: Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase I study evaluating the combination of etanercept with weekly docetaxel in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Etanercept (etanercept)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Tumors | Phase 1 | Status: COMPLETED